SECsense Logo

Kronos Bio, Inc. Reports Significant Event in Form 8-K Filing – December 2024

$KRON
Form 8-K
Filed on: 2024-12-27
Source
Kronos Bio, Inc. Reports Significant Event in Form 8-K Filing – December 2024

Here’s a summary and key insights extracted from the provided section of the financial report:

  1. Company Information:
  • Name: Kronos Bio, Inc.
  • CIK (Central Index Key): 0001741830
  • Entity Type: Corporation
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-39592
  • EIN (Employer Identification Number): 82-1895605
  • Address: 1300 So. El Camino Real Suite 400, San Mateo, CA 94402
  • Phone Number: 650-781-5200
  1. Filing Details:
  • Filing Type: Form 8-K
  • Filing Date: December 20, 2024
  1. Stock Information:
  • Common Stock Par Value: $0.001
  • Stock Ticker: KRON
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: December 19, 2024
  • End Date: December 19, 2024

Insights:

  • The filing is a Form 8-K, which is typically used to report significant events that shareholders should know about. This could indicate a noteworthy occurrence or change within the company on December 19, 2024.
  • The company operates in the biotechnology sector, as suggested by its name, which could imply developments related to drug discovery, clinical trials, or other related activities.
  • The low par value of the common stock suggests that the company may be in a growth stage, which is common for biotech firms.

This summary encapsulates the essential information from the financial report section, reflecting the company's status and recent activities as of the specified filing date.